Quarterly report [Sections 13 or 15(d)]

Cover
- Cover
Financial Statements
Notes to Financial Statements
Accounting Policies
- Basis of Presentation and Significant Accounting Policies (Policies)
Notes Tables
Notes Details

Schedule of Warrants Activity (Details)

v3.26.1

Schedule of Warrants Activity (Details)	3 Months Ended
Schedule of Warrants Activity (Details)	Mar. 31, 2026 USD ($) $ / shares shares
Equity [Abstract]
Total options outstanding, balance \| shares	7,222,821
Weighted average exercise price, balance \| $ / shares	$ 1.46
Aggregate intrinsic value, balance \| $
Total options outstanding, granted \| shares
Weighted average exercise price, granted \| $ / shares
Total options outstanding, exercised \| shares
Weighted average exercise price, exercised \| $ / shares
Total options outstanding, forfeited \| shares
Weighted average exercise price, forfeited \| $ / shares
Total options outstanding, balance \| shares	7,222,821
Weighted average exercise price, balance \| $ / shares	$ 1.46
Aggregate intrinsic value, balance \| $

- Definition

Share based compensation arrangement by share based payment award non-option equity instruments expirations in period weighted average exercise price.

+ References

No definition available.

+ Details

Name:	COCP_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirationsInPeriodWeightedAverageExercisePrice
Namespace Prefix:	COCP_
Data Type:	dtr-types:perShareItemType
Balance Type:	na
Period Type:	duration

- Definition

Share based compensation arrangement by share based payment award non-option equity instruments outstanding intrinsic value.

+ References

No definition available.

+ Details

Name:	COCP_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingIntrinsicValue
Namespace Prefix:	COCP_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	instant

- Definition

Share based compensation arrangement by share based payment award non-option equity instruments outstanding weighted average exercise price.

+ References

No definition available.

+ Details

Name:	COCP_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice
Namespace Prefix:	COCP_
Data Type:	dtr-types:perShareItemType
Balance Type:	na
Period Type:	instant

- Definition

Share based compensation arrangement by share based payment award non-option equity instruments exercises in period weighted average exercise price.

+ References

No definition available.

+ Details

Name:	COCP_ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisesInPeriodWeightedAverageExercisePrice
Namespace Prefix:	COCP_
Data Type:	dtr-types:perShareItemType
Balance Type:	na
Period Type:	duration

- Definition

Share based compensation arrangement by share based payment award non-option equity instruments grants in period weighted average exercise price.

+ References

No definition available.

+ Details

Name:	COCP_ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionEquityInstrumentsGrantsInPeriodWeightedAverageExercisePrice
Namespace Prefix:	COCP_
Data Type:	dtr-types:perShareItemType
Balance Type:	na
Period Type:	duration

- References

No definition available.

+ Details

Name:	us-gaap_EquityAbstract
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

- Definition

Number of non-option equity instruments exercised by participants.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (c)(1)(iv)(02)
-SubTopic 10
-Topic 718
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

+ Details

Name:	us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised
Namespace Prefix:	us-gaap_
Data Type:	xbrli:sharesItemType
Balance Type:	na
Period Type:	duration

- Definition

Number of shares under non-option equity instrument agreements that were cancelled as a result of occurrence of a terminating event.

+ References

+ Details

Name:	us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures
Namespace Prefix:	us-gaap_
Data Type:	xbrli:sharesItemType
Balance Type:	na
Period Type:	duration

- Definition

Net number of non-option equity instruments granted to participants.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (c)(1)(iv)(01)
-SubTopic 10
-Topic 718
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

+ Details

Name:	us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted
Namespace Prefix:	us-gaap_
Data Type:	xbrli:sharesItemType
Balance Type:	na
Period Type:	duration

- Definition

Number of equity instruments other than options outstanding, including both vested and non-vested instruments.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Topic 718
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (c)(1)(ii)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Topic 718
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (c)(1)(i)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

+ Details

Name:	us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber
Namespace Prefix:	us-gaap_
Data Type:	xbrli:sharesItemType
Balance Type:	na
Period Type:	instant

Schedule of Warrants Activity (Details)	3 Months Ended
Schedule of Warrants Activity (Details)	Mar. 31, 2026 USD ($) $ / shares shares
Equity [Abstract]
Total options outstanding, balance \| shares	7,222,821
Weighted average exercise price, balance \| $ / shares	$ 1.46
Aggregate intrinsic value, balance \| $
Total options outstanding, granted \| shares
Weighted average exercise price, granted \| $ / shares
Total options outstanding, exercised \| shares
Weighted average exercise price, exercised \| $ / shares
Total options outstanding, forfeited \| shares
Weighted average exercise price, forfeited \| $ / shares
Total options outstanding, balance \| shares	7,222,821
Weighted average exercise price, balance \| $ / shares	$ 1.46
Aggregate intrinsic value, balance \| $